North America Automated Breast Ultrasound Systems Market size exceeded USD 300 million in 2021 and is expected to witness 15% CAGR from 2022 to 2028.

A vast segment of the female population across the region is participating in a wide range of government initiatives to understand the importance of breast cancer screening. Numerous foundations across U.S. and Canada, including Susan Komen Foundation, National Breast Cancer Foundation, and Canadian Cancer Society are organizing breast cancer awareness events. These foundations are offering financial support to underprivileged women to undergo diagnostic tests for breast cancer.

Get more details on this report - Request Free Sample PDF

Similar initiatives will augment the regional market progress, to reduce high mortality rate associated with the chronic ailment. Technological advancements are being introduced in ABUS solutions to facilitate efficient screening of breast cancer in women who have dense breast tissues. In-depth research studies and scientific discoveries by medical researchers across the region are helping companies develop high-end diagnostic and treatment products. These products deliver superior diagnosis as well as reduce the total turnaround time.

Impact of COVID-19 crisis on the automated breast ultrasound systems market outlook

The advent of the novel coronavirus outbreak in 2020 influenced the healthcare sector in different ways, depending on the area of medicine. There were considerable disruptions among healthcare providers who catered to cancer patients, with a decline in doctor visits due to the risk of infection. Across the U.S. and Canada, there was a noticeable drop in the screening of breast cancer, breast cancer biopsies and overall cancer diagnosis during 2022-21. It was noted that, during the peak of the COVID-19 pandemic, the American College of Radiology (ACR) and the Society of Breast Imaging made attempts to persuade women to not ignore the cancer risk and resume screening, but the results of these awareness efforts are not completely known.

North America Market, By Product

The ABVS segment will gain remarkable momentum through 2028. ABVS enables early detection of breast cancer as it can produce high-resolution images of dense breast tissues within a few minutes, helping oncologists in preparing their treatment plans accordingly.

North America Market, By End-Use

The North America ABUS market share from the diagnostic imaging centers segment will account for a sizeable share by 2028. There is a rising presence of reputed diagnostic centers in the U.S. that provide high-quality care to patients. Many companies are opening new R&D centers across the region to help them create futuristic diagnostic technologies.

North America Market, By Country

Canada automated breast ultrasound systems (ABUS) market will showcase around 16% growth rate during the forecast period. According to a report by the Canadian Cancer Society, breast cancer is the second leading cause of death among Canadian women. The report further states that around 28,600 women in the country were diagnosed with breast cancer in 2022, representing 25% of all new cancer cases.

Many public agencies across Canada are also introducing initiatives to boost awareness among women and bring down the breast cancer mortality rate. For instance, the Canadian Cancer Society successfully raised more than USD 900,000 in 2022 through its annual Daffodil Ball, to fund various cancer research projects. This funding will also encourage medical device manufacturers to make innovations in automated breast ultrasound systems to make them more convenient and accurate.

Competitive Industry Landscape

Prominent players operating in the North America automated breast ultrasound systems market include GE Healthcare, Nova Medical Imaging Technology Co. Ltd, Koninklijke Philips N.V., Canon Medical Systems, Hitachi Ltd., Theraclion, Siemens AG and SonoCine Inc. These companies are adopting new product introduction strategies and collaborations to gain a strong competitive edge.